News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,649 Results
Type
Article (40028)
Company Profile (272)
Press Release (660349)
Multimedia
Podcasts (50)
Webinars (12)
Section
Business (205065)
Career Advice (2020)
Deals (35528)
Drug Delivery (97)
Drug Development (81230)
Employer Resources (172)
FDA (16201)
Job Trends (14909)
News (346412)
Policy (32640)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2572)
Accelerated approval (5)
Adcomms (20)
Allergies (82)
Alliances (49761)
ALS (86)
Alzheimer's disease (1377)
Antibody-drug conjugate (ADC) (123)
Approvals (16204)
Artificial intelligence (242)
Autoimmune disease (22)
Automation (16)
Bankruptcy (363)
Best Places to Work (11658)
BIOSECURE Act (20)
Biosimilars (105)
Biotechnology (191)
Bladder cancer (64)
Brain cancer (26)
Breast cancer (271)
Cancer (2143)
Cardiovascular disease (170)
Career advice (1687)
Career pathing (30)
CAR-T (146)
Cell therapy (410)
Cervical cancer (19)
Clinical research (66017)
Collaboration (819)
Compensation (518)
Complete response letters (19)
COVID-19 (2599)
CRISPR (38)
C-suite (232)
Cystic fibrosis (100)
Data (2089)
Decentralized trials (2)
Denatured (19)
Depression (41)
Diabetes (263)
Diagnostics (6375)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (119)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (91)
Earnings (86527)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112532)
Executive appointments (711)
FDA (17410)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (736)
Gene editing (102)
Generative AI (19)
Gene therapy (286)
GLP-1 (706)
Government (4423)
Grass and pollen (4)
Guidances (51)
Healthcare (18831)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (114)
Indications (28)
Infectious disease (2740)
Inflammatory bowel disease (137)
Inflation Reduction Act (10)
Influenza (50)
Intellectual property (92)
Interviews (311)
IPO (16531)
IRA (42)
Job creations (3664)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (468)
Leadership (16)
Legal (7943)
Liver cancer (72)
Lung cancer (308)
Lymphoma (146)
Machine learning (5)
Management (58)
Manufacturing (294)
MASH (63)
Medical device (13364)
Medtech (13369)
Mergers & acquisitions (19522)
Metabolic disorders (668)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1892)
NextGen: Class of 2025 (6549)
Non-profit (4488)
Northern California (2578)
Now hiring (39)
Obesity (358)
Opinion (208)
Ovarian cancer (73)
Pain (82)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (104)
Peanut (46)
People (57577)
Pharmaceutical (67)
Pharmacy benefit managers (18)
Phase I (20575)
Phase II (29078)
Phase III (21660)
Pipeline (1132)
Policy (135)
Postmarket research (2564)
Preclinical (8714)
Press Release (64)
Prostate cancer (100)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (373)
Real estate (5953)
Recruiting (65)
Regulatory (22291)
Reports (46)
Research institute (2326)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (129)
Series B (81)
Service/supplier (13)
Sickle cell disease (52)
Southern California (2220)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3625)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (30)
The Weekly (29)
United States (22375)
Vaccines (672)
Venture capitalists (42)
Weight loss (232)
Women's health (34)
Worklife (15)
Date
Today (180)
Last 7 days (546)
Last 30 days (2450)
Last 365 days (32987)
2025 (9682)
2024 (35331)
2023 (40179)
2022 (51287)
2021 (55835)
2020 (54154)
2019 (46644)
2018 (35124)
2017 (32222)
2016 (31629)
2015 (37707)
2014 (31454)
2013 (26499)
2012 (28770)
2011 (29426)
2010 (27525)
Location
Africa (721)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (38001)
Australia (6227)
California (5896)
Canada (1961)
China (501)
Colorado (260)
Connecticut (265)
Delaware (138)
Europe (81595)
Florida (870)
Georgia (202)
Idaho (58)
Illinois (520)
India (26)
Indiana (306)
Iowa (10)
Japan (155)
Kansas (103)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (868)
Massachusetts (4402)
Michigan (216)
Minnesota (383)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1676)
New Mexico (28)
New York (1681)
North Carolina (947)
North Dakota (7)
Northern California (2578)
Ohio (201)
Oklahoma (14)
Oregon (34)
Pennsylvania (1325)
Puerto Rico (11)
Rhode Island (32)
South America (1099)
South Carolina (21)
South Dakota (1)
Southern California (2220)
Tennessee (100)
Texas (879)
Utah (173)
Virginia (141)
Washington D.C. (62)
Washington State (543)
West Virginia (3)
Wisconsin (51)
700,649 Results for "shoreline biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SHORELINE BIOSCIENCES TO PRESENT AT 2024 STIFEL HEALTHCARE CONFERENCE
November 18, 2024
·
1 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
Biotech Beach
Shoreline Biosciences to Participate at the 2023 Wedbush Pacgrow Healthcare Conference
Shoreline Biosciences, Inc., a biopharmaceutical company developing effective and differentiated cellular immunotherapies based on induced pluripotent stem cells derived natural killer cells and macrophages, announced that it will participate in the 2023 Wedbush Pacgrow Healthcare Conference taking place August 8-9, 2023 in New York, NY.
August 3, 2023
·
1 min read
Press Releases
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds
April 23, 2025
·
4 min read
Press Releases
Xenetic Biosciences, Inc. Releases Virtual Investor “What This Means” Segment
April 10, 2025
·
5 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
·
7 min read
Biotech Beach
Shoreline Biosciences Wins a Comprehensive Summary Judgement Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on IPSC Generation and Use
Shoreline Biosciences, Inc. announced a major milestone in its patent litigation with Fate Therapeutics, Inc. and the Whitehead Institute in the U.S. District Court for the Southern District of California.
September 7, 2023
·
2 min read
Press Releases
Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv) Franchise Acquisition from Coherus BioSciences, Inc., Expanding U.S. Biosimilar Portfolio
April 14, 2025
·
9 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Press Releases
Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results
March 19, 2025
·
6 min read
1 of 70,065
Next
